Autoantibodies persist in relatives to systemic lupus erythematosus patients during 12 years follow-up

Lupus

Volumn 26, Issue 7, 2017, Pages 723-728

  Langkilde, H ^a   Voss, A ^a   Heegaard, N ^a   Laustrup, H ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

autoantibodies; follow up; population based; relatives; self reported health; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; ANTINUCLEAR ANTIBODY;

ADULT; AGED; ALOPECIA; ANTIBODY PRODUCTION; ARTHRALGIA; ARTICLE; COMPARATIVE STUDY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DRY EYE; FATIGUE; FEMALE; FIRST-DEGREE RELATIVE; FOLLOW UP; HUMAN; JOINT SWELLING; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MYALGIA; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RAYNAUD PHENOMENON; RETROPERITONEAL FIBROSIS; RHEUMATIC DISEASE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TIME OF DEATH; WEGENER GRANULOMATOSIS; AGE; AUTOIMMUNE DISEASE; FAMILY; IMMUNOLOGY; MIDDLE AGED; TIME FACTOR;

AGE FACTORS; AGED; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOIMMUNE DISEASES; FAMILY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; TIME FACTORS;

EID: 85019032843     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316676378     Document Type: Article

References (33)

1. Tsokos GC,. Systemic lupus erythematosus. N Engl J Med 2011; 365: 2110-2121.
2. Gaipl US, Kuhn A, Sheriff A, et al. Clearance of apoptotic cells in. Curr Dir Autoimmun 2006; 9: 173-187.
3. Tan P, Pang G, Wilson JD,. Immunoglobulin production in vitro by peripheral blood lymphocytes in systemic lupus erythematosus: helper T cell defect and B cell hyperreactivity Immunoglobulin production in SLE. Clin Exp Immunol 1981; 44: 548-554.
4. Liu Y, Zhu T, Cai G, et al. Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus. Lupus 2011; 20: 620-627.
5. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-1533.
6. Alarcón-Segovia D, Alarcón-Riquelme ME, Cardiel MH, et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005; 52: 1138-1147.
7. Somers EC, Antonsen S, Pedersen L, Sørensen HT,. Parental history of lupus and rheumatoid arthritis and risk in offspring in a nationwide cohort study: does sex matter? Ann Rheum Dis 2013; 72: 525-529.
8. Lindqvist AK, Steinsson K, Johanneson B, et al. A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J Autoimmun 2000; 14: 169-178.
9. Deapen D, Escalante A, Weinrib L, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 311-318.
10. Moser KL, Kelly JA, Lessard CJ, Harley JB,. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 2009; 10: 373-379.
11. Bruner BF, Guthridge JM, Lu R, et al. Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members. Arthritis Rheum 2012; 64: 3677-3686.
12. Laustrup H, Heegaard NHH, Voss A, Green A, Lillevang ST, Junker P,. Autoantibodies and self-reported health complaints in relatives of systemic lupus erythematosus patients: a community based approach. Lupus 2004; 13: 792-799.
13. Navarra SV, Ishimori ML, Uy EA, et al. Studies of Filipino patients with systemic lupus erythematosus: autoantibody profile of first-degree relatives. Lupus 2011; 20: 537-543.
14. Pollak VE, Enno M, Kark RM,. Antinuclear factors in the serum of relatives of patients with systemic lupus erythematosus. Lancet 1960, pp. 1958-1960.
15. Cárdenas-Roldán J, Rojas-Villarraga A, Anaya J-M,. How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med 2013; 11: 73.
16. Wither J, Cai Y, Lim S, et al. Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity. Arthritis Res Ther 2008; 10: R108-R108.
17. Laustrup H, Voss A, Green A, Junker P,. Occurrence of systemic lupus erythematosus in a Danish community: an 8-year prospective study. Scand J Rheumatol 2009; 38: 128-132.
18. Laustrup H, Voss A, Green A, Junker P,. SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study. Lupus 2010; 19: 239-246.
19. Humbel RL,. Detection of antinuclear antibodies by immunofluorscense. Clin Rheumatol 1990, pp. 9(1 Suppl 1): 96-99.
20. Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH,. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 1994; 21: 302-306.
21. Navarra SV, Ishimori MI, Uy EA, et al. Studies of Filipino patients with systemic lupus erythematosus: autoantibody profile of first-degree relatives. Lupus 2011; 20: 537-543.
22. Ramos PS, Kelly JA, Gray-McGuire C, et al. Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus. Genes Immun 2006; 7: 417-432.
23. Juby AG, Davis P,. Prevalence and disease associations of certain autoantibodies in elderly patients. Clin Invest Med 1998; 21: 4-11.
24. Nilsson B-O, Skogh T, Ernerudh J, et al. Antinuclear antibodies in the oldest-old women and men. J Autoimmun 2006; 27: 281-288.
25. Xavier RM, Yamauchi Y, Nakamura M, et al. Antinuclear antibodies in healthy aging people: a prospective study. Mech Ageing Dev 1995; 78: 145-154.
26. Nass FR, Kotze LM, Nisihara RM, de Messias-Reason IT, da Rosa Utiyama SR,. Autoantibodies in relatives of celiac disease patients: a follow-up of 6-10 years. Arq Gastroenterol 2012; 49: 199-203.
27. Faria AC, Barcellos KSA, Andrade LEC,. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus. J Rheumatol 2005; 32: 1267-1272.
28. ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CGM,. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. Arthritis Rheum 1990; 33: 634-643.
29. Harel-Meir M, Sherer Y, Shoenfeld Y,. Tobacco smoking and autoimmune rheumatic diseases. Nat Clin Pract Rheumatol 2007; 3: 707-715.
30. Young KA, Terrell DR, Guthridge JM, et al. Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls. Lupus 2014; 23: 360-369.
31. Pedersen JK, Kjær NK, Svendsen AJ, Hørslev-Petersen K,. Incidence of rheumatoid arthritis from 1995 to 2001: Impact of ascertainment from multiple sources. Rheumatol Int 2009; 29: 411-415.
32. Doria A, Zen M, Canova M, et al. SLE diagnosis and treatment: when early is early. Autoimmun Rev 2010, pp. 10: 55-60.
33. James JA, Kim-Howard XR, Bruner BF, et al. Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus. Lupus 2007; 16: 401-409.